Monitoring both cytokines and complement factors in drug development has become increasingly important, as the movement toward personalized treatments for cancers and genetic diseases has spurred research and development into biologics, vaccines, and small molecules that can have unintended consequences due to their immunomodulatory effects. 

First-in-Human Solution for Small and Large Molecules

Clinical Pathology Reference Data for the Philippine Cynomolgus Monkey for Preclinical Toxicology Studies

Comparison of Safety Pharmacology End Points Used on Toxicology Studies Across Differing Cynomolgus Monkey Origins

Cross-Comparison of Biomarker Assay Performance in Nonhuman Primates

Cross-Comparison of Immunophenotyping Assay Performance in Nonhuman Primates

Development of a Canine Prostatectomy Model

Development of a Novel Early Intervention Stabilization for Abdominal Aortic Aneurysms

Historical Background Data in Juvenile Cynomolgus Monkeys

Subscribe to